肾细胞癌合并静脉瘤栓中 Bland 血栓对生存的不良影响
本研究基于 5 家三级医疗中心的多机构数据库,纳入 446 例接受肾切除加腔静脉血栓取出术的局部晚期肾肿瘤患者,其中 174 例伴 Bland 血栓、272 例不伴。
要点
- Bland 血栓患者基线体能状态更差、分期更高、淋巴结转移更多、核分级更高。
- 匹配后 Bland 血栓组中位肿瘤特异性生存显著更短(28.1 个月 vs 156.8/76.7 个月)。
- 多因素分析显示 Bland 血栓与肿瘤特异性死亡风险独立相关(HR 4.33)。
核心结论
- 在接受手术治疗的肾肿瘤合并静脉瘤栓患者中,Bland 血栓的存在与不良生存结局相关。
- 该发现可能对患者咨询、手术选择及临床试验入组有重要意义。
研究设计与样本
- 多机构回顾性数据库,来自 5 家三级医疗中心。
- 初始队列 579 例,446 例符合纳入标准(174 例伴 Bland 血栓,272 例不伴)。
- 采用最近邻及多重匹配倾向性评分匹配队列比较 Bland 血栓与非 Bland 血栓患者。
- 多因素分析评估肿瘤特异性生存预测因素。
临床怎么用
- 对肾肿瘤合并静脉瘤栓患者,术前识别 Bland 血栓可辅助患者咨询与手术选择。
- Bland 血栓的存在可作为临床试验入组时考虑的不良预后因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the presence of bland (nontumor) thrombus in advanced renal cell carcinoma and assess the impact of this finding on cancer-specific survival. METHODS: A multi-institutional database of patients treated with nephrectomy with caval thrombectomy for locally-advanced renal tumors was assembled from 5 tertiary care medical centers. Using clinicopathologic variables including patient age, body mass index, Eastern Cooperative Oncology Group performance status, tumor stage, grade, nodal status and histology, and nearest-neighbor and multiple-matching propensity score matched cohorts of bland thrombus vs nonbland thrombus patients were assessed. Multivariable analysis for predictors of cancer-specific survival was performed. RESULTS: From an initial cohort of 579 patients, 446 met inclusion criteria (174 with bland thrombus, 272 without). At baseline, patients with bland thrombus had significantly worse performance status, higher tumor stage, higher prevalence of regional nodal metastases and higher nuclear grade (P < .01 for all). In both nearest-neighbor and multiple-matching propensity score matched cohorts, the presence of bland thrombus presence was associated with inferior median cancer-specific survival (28.1 months vs 156.8 months, and 28.1 months vs 76.7 months, P < .001 for both). The presence of bland thrombus remained independently associated with an increased risk of cancer-specific mortality on multivariable analysis (hazard ratio 4.33, 95% confidence interval 2.79-6.73, P < .001). CONCLUSION: Presence of bland thrombus is associated with adverse survival outcomes in patients treated surgically for renal tumors with venous tumor thrombus. These findings may have important implications in patient counseling, selection for surgery and inclusion in clinical trials.
引用
- Hutchinson R, Rew C, Chen G, et al. The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. Urology. 2018. PMID: 29499258. doi:10.1016/j.urology.2018.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。